Related Experiment Video
Updated: May 20, 2026

Real-Time Void Spot Assay
Published on: February 10, 2023
Loss of dicer exacerbates cyclophosphamide-induced bladder overactivity by enhancing purinergic signaling
Shu Zhang1, Jian-Wei Lv, Ping Yang
1The Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Abstract:
microRNAs (miRNAs) have regulated the expression and function of genes implicated in many pathological settings, but their impact on the pathoetiological characteristics of overactive bladder (OAB) largely remains unknown. We have generated a mouse model in which adult mice can be induced for detrusor deletion of Dicer, an enzyme essential for miRNA processing. Targeted deletion of Dicer did not lead to a significant change for detrusor functionality under physiological conditions; however, loss of Dicer exacerbated cyclophosphamide-induced OAB, manifested by the higher severity of altered detrusor contractile force and sensitivity, abnormal urodynamics, and enhanced macrophage infiltration. Mechanistic studies revealed that loss of Dicer may impair the expression of miRNAs that are capable of targeting P2x mRNAs. As a result, mice deficient in Dicer manifest enhanced P2X expression in the detrusor on cyclophosphamide treatment, predisposing to the increased risk for OAB development. More important, studies using bladder biopsy samples of patients with OAB also demonstrated similar results as those found in animals. Taken together, our results suggest that miRNAs modulate OAB susceptibility by regulating purinergic signaling, in which the pathogenic insult induces the expression of miRNAs capable of targeting P2X mRNAs to suppress OAB symptoms.
Insights
MicroRNAs (miRNAs) play a crucial role in overactive bladder (OAB). Loss of miRNAs exacerbates OAB symptoms by increasing P2X expression, highlighting their protective function in purinergic signaling.
Area of Science:
- Urology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) regulate gene expression in various pathologies.
- The role of miRNAs in the pathoetiology of overactive bladder (OAB) is largely unknown.
Purpose of the Study:
- To investigate the impact of miRNA processing on OAB development and characteristics.
- To elucidate the role of Dicer-dependent miRNAs in regulating detrusor function and OAB pathogenesis.
Main Methods:
- Generated a mouse model with inducible Dicer deletion in the detrusor muscle.
- Induced OAB using cyclophosphamide and assessed detrusor function, urodynamics, and macrophage infiltration.
- Analyzed miRNA targeting of P2x mRNAs and P2X expression in detrusor tissue.
- Examined human OAB patient bladder biopsies for similar molecular changes.
Main Results:
- Dicer deletion alone did not significantly alter detrusor function under physiological conditions.
- Loss of Dicer exacerbated cyclophosphamide-induced OAB, showing increased severity in contractile force, sensitivity, abnormal urodynamics, and macrophage infiltration.
- Dicer deficiency led to impaired miRNA expression targeting P2x mRNAs, resulting in enhanced P2X expression in the detrusor.
- Similar findings were observed in human OAB patient bladder biopsies, indicating conserved mechanisms.
Conclusions:
- miRNAs modulate OAB susceptibility by regulating purinergic signaling pathways.
- Loss of Dicer impairs miRNA-mediated suppression of P2X expression, predisposing to OAB.
- These findings suggest a protective role for specific miRNAs in suppressing OAB symptoms via purinergic signaling regulation.
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Crohn's Disease
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
GPCRs Regulate Adenylyl Cylase Activity
Two...
Drugs for Treatment of Constipation-Predominant IBS
